Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of the Genotype of TNFα with the Efficiency of the Intensive Phase of Chemotherapy and Formation of the Sizes of Destruction Cavities in Patients with Pulmonary Tuberculosis.

Bulletin of experimental biology and medicine·2024
Same author

A Large Marine Bird (Aves: Procellariiformes) from the Eocene of Western Siberia.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections·2024
Same author

[Therapy and Rehabilitation of Patients with Pulmonary Tuberculosis and Different Treatment Adherence].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2016
Same author

[Immunomodulator Intensification of Etioropic Therapy in Patients with Advanced Pulmonary Tuberculosis].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2016
Same author

[Effectiveness of immunomodulating therapy of pulmonary tuberculosis with cycloferon].

Klinicheskaia meditsina·2013
Same author

[Regulations for decontamination of surfaces polluted as a result of chemical accidents (concept approaches)].

Meditsina truda i promyshlennaia ekologiia·2011

Related Experiment Video

Updated: Jul 9, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

[Immunological correction in progressive pulmonary tuberculosis].

A A Maslennikov, V F Kamenev, V M Kolomiets

    Problemy Tuberkuleza I Boleznei Legkikh
    |November 28, 2007
    PubMed
    Summary

    Immunological correction significantly improved treatment outcomes for progressive pulmonary tuberculosis patients. This method enhanced clinical cure rates and reduced mortality when combined with standard antituberculosis therapy.

    Area of Science:

    • Immunology
    • Infectious Diseases
    • Pulmonology

    Context:

    • Progressive pulmonary tuberculosis presents significant treatment challenges.
    • Standard antituberculosis therapy can have limited efficacy in severe cases.
    • Immunological status plays a crucial role in tuberculosis progression.

    Purpose:

    • To evaluate the efficacy of immunological correction as an adjunct to standard antituberculosis therapy.
    • To assess the impact of paravasal lymphotrophic immunological correction on clinical cure rates and mortality in pulmonary tuberculosis patients.

    Summary:

    • A study involving 154 patients with progressive pulmonary tuberculosis compared standard therapy with therapies including immunological correction.
    • Patients receiving immunological correction, particularly with individualized regimens, showed significantly higher clinical cure rates (up to 94.7%) and lower mortality compared to standard therapy alone.

    Related Experiment Videos

    Last Updated: Jul 9, 2026

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
    06:32

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

    Published on: September 19, 2016

  • Early integration of immunological correction based on patient immunological status is recommended for severe forms of pulmonary tuberculosis.

    • Impact:

    • Immunological correction offers a promising strategy to improve outcomes for patients with severe pulmonary tuberculosis.
    • This approach may lead to reduced mortality and enhanced recovery rates in challenging tuberculosis cases.
    • The findings support the early use of tailored immunological interventions in tuberculosis management.